The Heart Damper is a patented minimally invasive cardiac device designed to be stably fitted into the left ventricle by either transapical or transfemoral arterial delivery, and to provide an increase in the ejection fraction and cardiac efficiency by:
reducing the volume of the left ventricle;
exploiting the residual contractile capacity of the failing heart, moving up during the systolic phase and stretching down to its resting position with diastole.
Once in place, the device does not require any external power source.
The Heart Damper will be indicated for patients with impaired LVEF (left ventricular ejection fraction) and SHF (systolic heart failure).
The Heart Damper has been invented by professor Roberto Parravicini, serial inventor and heart surgeon. The Heart Damper is protected by patents issued in Italy (n. 1400503), in the US (n. 8.684.906), in Europe (n. 2579909), in Japan (n. 5809257) and in Russia (n. 2573946) and by additional patents pending in major countries worldwide. All patents and Eucardia® registered trademark are owned by Eucardia Srl.